NCT06381141
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06381141
Title A Study of CLN-619 (Anti-MICA/MICB Antibody) in Patients With Relapsed and Refractory Multiple Myeloma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Cullinan Therapeutics Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic Phoenix Arizona 85054 United States Details
Mayo Clinic Jacksonville Florida 32224 United States Details
Mayo Clinic Rochester Minnesota 55905 United States Details
Mt. Sinai New York New York 10029 United States Details
Memorial Sloan Kettering (MSK) New York New York 10065 United States Details
Levine Cancer Institute Charlotte North Carolina 28204 United States Details
Levine Cancer Institute Winston-Salem North Carolina 27157 United States Details
University of Texas Southwestern Medical Center Dallas Texas 75390 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field